Teva-Ropinirole · DIN 02316862 · 2 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Teva-Ropinirole · DIN 02316862
Manufacturer: Teva Canada Limited; listing date 2009-09-30
Health Canada: Marketed since 2020-05-22 · brand TEVA-ROPINIROLE · ATC N04BC04 ROPINIROLE · form Tablet · route Oral · ingredients ROPINIROLE (ROPINIROLE HYDROCHLORIDE) 2 MG · company Teva canada limited · schedule Prescription
Teva-Ropinirole: Formulary list price $0.63 per unit (the source does not state the unit; exact figure $0.6338). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02316862)
Source record
DIN 02316862: Teva-Ropinirole
Raw flags: sec3=Y
Item: 920000291; group id 956; item number 2271; lccId None; manufacturer id TEV
Source form: Tab; strength: 2mg
Recorded listing: General benefit
Source prices (unrounded): $0.6338; ministry $0.6338
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02316862
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=80236
Interchangeable products
Ran-Ropinirole · DIN 02314061 · $0.6338
ReQuip · DIN 02232568 · not recorded
Shortage status: not checked (no credentials)